FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain ...
The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.
The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback